Neurovalens and Flow Neuroscience push tDCS tech: new hope for anxiety relief

With only 28% of anxiety sufferers receiving treatment, startups like Neurovalens and Flow Neuroscience are pioneering non-invasive brain stimulation (tDCS) to bridge this gap. This report covers cutting-edge devices and digital therapies transforming anxiety care amid rising demand, especially among children.

Sources:
NDTV+1
Updated 1h ago
Tab background
Sources: NDTV
Anxiety disorders affect millions globally, yet only 28% of sufferers receive treatment, hindered by long waiting lists and rising demand, especially among children, with 500 daily referrals to mental health services post-pandemic.

Neurovalens and Flow Neuroscience are pioneering the use of transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique, to provide new avenues for anxiety relief.

This technology applies mild electrical currents to targeted brain regions to modulate neural activity associated with mood and anxiety.

Other neurotechnology startups complement this approach: Moonbird offers a handheld device guiding paced breathing through gentle movements, while Parasym uses mild electrical micro impulses on the vagus nerve to regulate mood and stress.

Digital therapies like Headspace and ieso provide structured meditation and cognitive behavioral therapy (CBT) programs, expanding access to mental health support.

“Neurotechnology can, at least in part, help fill the gap before symptoms get worse,” experts say, highlighting the potential of these innovations to address treatment shortages.

As anxiety rates climb, especially among youth, these emerging technologies offer promising, accessible options to supplement traditional care and improve outcomes.

The integration of hardware and software solutions marks a significant shift in anxiety management, aiming to reach those underserved by conventional mental health services.
Sources: NDTV
Neurovalens and Flow Neuroscience are advancing transcranial direct current stimulation (tDCS) technology, offering new hope for anxiety relief amid rising mental health demands. With only 28% of anxiety sufferers receiving treatment, these non-invasive brain stimulation methods aim to fill treatment gaps and ease symptoms.
Section 1 background
Worldwide, only about 28% of people with anxiety receive treatment. But it isn't always easy to get professional help, with long waiting lists in many countries.
Representative
Cambridge
NDTV
Key Facts
  • Only about 28% of people with anxiety worldwide receive treatment, largely due to long waiting lists in many countries.NDTV
  • Startups are developing both hardware and software solutions to help manage anxiety symptoms before they worsen.NDTV
  • Moonbird offers a handheld device that guides users through paced breathing using gentle physical movements felt in the hand.NDTV
  • Parasym provides a wearable device that applies mild electrical micro impulses to the vagus nerve, which regulates mood and stress.NDTV
  • Digital platforms like Headspace and ieso offer structured meditation and cognitive behavioural therapy (CBT) programmes for anxiety management.NDTV
  • Children’s anxiety referrals have more than doubled post-pandemic, with 500 children per day now being referred to mental health services.1
  • Neurovalens and Flow Neuroscience are exploring non-invasive brain stimulation techniques such as transcranial direct current stimulation (tDCS) for anxiety relief.1
Key Stats at a Glance
Percentage of people with anxiety worldwide who receive treatment
28%
NDTV
Number of children referred per day to mental health services for anxiety
500 children/day
1
Article not found
⌂ CuriousCats.ai

Article

‹

Source Citations